Natus Medical EBIT

Natus Medical (NTUS) currently reports a EBIT of $33M as of March 2022. That compares with $-9.3M in the prior-year period — up 454.7% year over year. That is below the Healthcare sector average of $22B. Use the charts on this page to explore Natus Medical's EBIT history and peer comparisons.

Natus Medical's EBIT increased from $-9.3M to $33M — a 454.7% year-over-year increase (period ending March 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Natus Medical's EBIT of $33M is lower than the Healthcare sector average of $22B. That is roughly 99.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Natus Medical reported $33M in EBIT as of March 2022. That compares with $-9.3M in the prior-year period — up 454.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $33M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for Natus Medical, and consider following NTUS for alerts when major investors trade the stock.